Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRAS&lt;sup&gt;G12C&lt;/sup&gt;–EGFR Inhibition in Colorectal Cancer

Rona Yaeger; Riccardo Mezzadra; Jenna Sinopoli; Yu Bian; Michelangelo Marasco; Esther Kaplun; Yijun Gao; HuiYong Zhao; Arnaud Da Cruz Paula; Yingjie Zhu; Almudena Chaves Perez; Kalyani Chadalavada; Edison Tse; Sudhir Chowdhry; Sydney Bowker; Qing Chang; Besnik Qeriqi; Britta Weigelt; Gouri J. Nanjangud; Michael F. Berger; Hirak Der‐Torossian; Kenna Anderes; Nicholas D. Socci; Jinru Shia; Gregory J. Riely; Yonina R. Murciano‐Goroff; Bob T. Li; James G. Christensen; Jorge S. Reis‐Filho; David B. Solit; Elisa de Stanchina; Scott W. Lowe; Neal Rosen; Sandra Misale

doi:10.1158/2159-8290.30849238

Abstract

Patients Characteristics

Related Publications

Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma

James Bean , Gregory J. Riely , Marissa N. Balak +4 more

Abstract Purpose: Somatic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are associated with sensitivity of lung adenocarcinomas to ...

2008 Clinical Cancer Research 276 citations

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

Sujaya Srinivasan , Stefan Kirov , Joseph D. Szustakowski +66 more

Abstract KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups o...

2018 Cancer Discovery 1505 citations

KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors

David S. Hong , Marwan Fakih , John H. Strickler +31 more

Sotorasib showed encouraging anticancer activity in patients with heavily pretreated advanced solid tumors harboring the KRAS p.G12C mutation. Grade 3 or 4 treatment-rela...

2020 New England Journal of Medicine 1570 citations

Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer

Takayuki Kosaka , Yasushi Yatabe , Hideki Endoh +3 more

Abstract Recently it has been reported that mutations in the tyrosine kinase domain of the epidermal growth factor receptor(EGFR) gene occur in a subset of patients with lung ca...

2004 Cancer Research 1218 citations

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations

Daniel Sanghoon Shin , Jesse M. Zaretsky , Helena Escuin-Ordinas +24 more

Abstract Loss-of-function mutations in JAK1/2 can lead to acquired resistance to anti-programmed death protein 1 (PD-1) therapy. We reasoned that they may also be involved in pr...

2016 Cancer Discovery 1216 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

CrossRef

Cite This

APA Style

                            
                                    Rona Yaeger, 
                                
                                    Riccardo Mezzadra, 
                                
                                    Jenna Sinopoli
                                
                                et al.
                            
                            (2025). 
                            Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRAS&lt;sup&gt;G12C&lt;/sup&gt;–EGFR Inhibition in Colorectal Cancer. 
                            
                            .
                            https://doi.org/10.1158/2159-8290.30849238

Identifiers

DOI: 10.1158/2159-8290.30849238

Data Quality

Data completeness: 66%

Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRAS<sup>G12C</sup>–EGFR Inhibition in Colorectal Cancer

Abstract

Related Publications

Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with <i>EGFR</i>-Mutant Lung Adenocarcinoma

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors

Mutations of the <b> <i>Epidermal Growth Factor Receptor</i> </b> Gene in Lung Cancer

Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations